Literature DB >> 100084

Trifluridine in resistant human herpetic keratitis.

R A Hyndiuk, R E Charlin, T V Alpren, R O Schultz.   

Abstract

Patients with active dendritic herpetic keratitis that was unresponsive to topical idoxuridine or vidarabine therapy were treated topically with a 1% solution of trifluridine. The dendritic ulcers healed in an average time of 6.1 days. All patients tolerated the drug well except for one patient in whom a reversible crystalline epithelial keratitis developed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100084     DOI: 10.1001/archopht.1978.03910060351011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 2.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

3.  Aciclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial.

Authors:  C la Lau; J A Oosterhuis; J Versteeg; G van Rij; J G Renardel de Lavalette; A Craandijk; W R Lamers; T Mierlobensteyn
Journal:  Doc Ophthalmol       Date:  1981-03-20       Impact factor: 2.379

4.  Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?

Authors:  Afsun Sahin; Pedram Hamrah
Journal:  Ophthalmol Eye Dis       Date:  2012-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.